On July 17, Akeso Bio fell 3.63% in regular trading, trading at 93.0 HKD/share, with turnover of HK$455 million.
Within the Biotechnology sector where Akeso Bio belongs, the overall sector performance was weak. Among individual stocks, 3SBIO down 6.64%, Remegen down 6.88%, SKB Bio down 4.11%, Innovent Bio down 2.44%, BeiGene down 1.99%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)